Sonoma Pharmaceuticals, Inc.'s Net Worth

$8.97 Million

Estimate Recalculated Sep 8, 2024 07:24PM EST

Who is Sonoma Pharmaceuticals, Inc.?

Sonoma Pharmaceuticals, Inc. has an estimated net worth of $8.97 Million. This is based on reported shares in Ruthigen, Inc..

SEC CIK

Sonoma Pharmaceuticals, Inc.'s CIK is 0001367083

Past Insider Trading and Trends

2015 was Sonoma Pharmaceuticals, Inc.'s most active year for disposing of shares, totalling 3 transactions. Sonoma Pharmaceuticals, Inc.'s most active month to dispose stocks was the month of May. In 2015 Sonoma Pharmaceuticals, Inc. cashed out on 2,000,000 shares for a total of $5,500,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ruthigen, Inc. (PULM) Snapshot price: $2.1

Investor

Sonoma Pharmaceuticals, Inc. owns 1,650,000 units of Common Stock, $0.0001 par value per share which is worth $3,465,000.00. Sonoma Pharmaceuticals, Inc. used to own units in Common Stock $0.0001 per value share but no longer holds any shares there. In the year 2014 Sonoma Pharmaceuticals, Inc. disposed a total of 2,000,000 shares of Ruthigen, Inc. equalling to $5,500,000.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.65M
$2.75
-$4,537,500.00
0
Jun 16 - Jun 17
Form 4
-17.50%
-350.00K
$2.75
-$962,500.00
1.65M
Mar 23
Form 3
—
0
—
—
0
No matching records found